Her-2/neu gene amplification compared with HER-2/neu protein overexpression on ultrasound guided core-needle biopsy specimens of breast carcinoma

Pathology and Oncology Research

Volumn 7, Issue 4, 2001, Pages 279-283

  Kaya, Handan ^a   Ragazzini, Teresa ^a   Aribal, Erkin ^a   Güney, Ilter ^b   Kotilo lu, Esin ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast carcinoma; FISH; Her 2 neu; Immunohistochemistry

Indexed keywords

MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GENETICS; CANCER STAGING; CANCER SURGERY; CELL INFILTRATION; CHROMOSOME 17; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEEDLE BIOPSY; ONCOGENE NEU; PAGET NIPPLE DISEASE; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; NEOPLASM STAGING; PAGET'S DISEASE, MAMMARY; RECEPTOR, ERBB-2; ULTRASONOGRAPHY, MAMMARY;

EID: 0035716542     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032384     Document Type: Article

References (21)

1. Stereotactic breast biopsy accurate, minimally invasive, and cost effective
2. The role of stereotactic biopsy assessment of nonpalpable breast lesions
3. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor
4. The neu oncogene encodes an epidermal growth factor receptor-related protein
5. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
6. Correlations between the mammographic features of ductal carcinoma in situ (DC1S) and C-erbB-2 oncogene expression
7. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
8. Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use
9. Determination of Her-2/neu status in breast carcinoma: Comparative analysis of immunohistochemistry and fluorescent in situ hybridization
10. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
11. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization
12. Her-2/neu gene amplification compared with Her-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
13. The combination of in situ hybridization and immunohistochemical analysis: An evaluation of Her2/neu expression in paraffin-embedded breast carcinomas and adjacent normal appearing breast epithelium
14. c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients
15. Int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction
16. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
17. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors
18. The neu-protein and breast cancer
19. The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy
20. Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
21. Discrepancies in clinical laboratory testing of eligibility for transtuzumab therapy: Apparent immunohistochemical false positives do not get the message